Key facts
- Tasso’s last known valuation is $229.5M (Nov 2021).
- It has raised $122.7M across 1 recorded rounds; the latest was Later Stage VC (Series B) ($99.5M) in Nov 2021.
- Notable investors include Techstars, MedTech Innovator, RA Capital Management, United States Department of War, SVB Financial Group (Dallas) — 24 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 24 names
- ·Watchlist + deal alerts for Tasso
Funding rounds
1 roundsAbout Tasso
Manufacturer of blood collection devices intended to facilitate self-collection of blood samples. The company's devices are disposable, small in size, and have an interchangeable cartridge to ensure that the right blood preparation starts as soon as the sample is taken, enabling patients to painlessly administer their blood samples and mail them back to the lab for analysis in a hassle-free manner.
- Industry
- Diagnostic Equipment
- Sector
- Healthcare
- HQ
- Seattle, WA, United States
- Founded
- 2012
- Employees
- 100
- Website
- tassoinc.com/
- Ownership
- Privately Held (backing)
Tasso doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Tasso shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Tasso in its N-PORT filings yet. We sweep new filings monthly.